Summary
GlobalData's Medical Devices sector report, “Liver Dialysis Equipment - Medical Devices Pipeline Assessment, 2017" provides an overview of Liver Dialysis Equipment currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Liver Dialysis Equipment pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Liver Dialysis Equipment under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Liver Dialysis Equipment and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Liver Dialysis Equipment under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
Alliqua BioMedical Inc
Excorp Medical Inc
Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV
Hep-Art Medical Devices BV
University College London
University of Minnesota
Vital Therapies Inc
Yaqrit Ltd
'
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 Liver Dialysis Equipment Overview 5
3 Products under Development 6
3.1 Liver Dialysis Equipment - Pipeline Products by Stage of Development 6
3.2 Liver Dialysis Equipment - Pipeline Products by Territory 7
3.3 Liver Dialysis Equipment - Pipeline Products by Regulatory Path 8
3.4 Liver Dialysis Equipment - Pipeline Products by Estimated Approval Date 9
3.5 Liver Dialysis Equipment - Ongoing Clinical Trials 10
4 Liver Dialysis Equipment - Pipeline Products under Development by Companies 11
4.1 Liver Dialysis Equipment Companies - Pipeline Products by Stage of Development 11
4.2 Liver Dialysis Equipment - Pipeline Products by Stage of Development 11
5 Liver Dialysis Equipment Companies and Product Overview 12
5.1 Alliqua BioMedical Inc Company Overview 12
5.1.1 Alliqua BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview 12
5.2 Excorp Medical Inc Company Overview 13
5.2.1 Excorp Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 13
5.3 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Company Overview 15
5.3.1 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Pipeline Products & Ongoing Clinical Trials Overview 15
5.4 Hep-Art Medical Devices BV Company Overview 16
5.4.1 Hep-Art Medical Devices BV Pipeline Products & Ongoing Clinical Trials Overview 16
5.5 University College London Company Overview 17
5.5.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 17
5.6 University of Minnesota Company Overview 18
5.6.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 18
5.7 Vital Therapies Inc Company Overview 19
5.7.1 Vital Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.8 Yaqrit Ltd Company Overview 20
5.8.1 Yaqrit Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
6 Liver Dialysis Equipment- Recent Developments 22
6.1 Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook 22
6.2 Mar 28, 2017: Alliqua BioMedical Raises USD3.8 Million in Public Offering of Shares 22
6.3 Mar 22, 2017: Vital Therapies Announces Underwriters Exercise of Over-Allotment of Public Offering of Shares 23
6.4 Mar 07, 2017: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2016 Financial Results 23
6.5 Mar 07, 2017: Vital Therapies Announces Fourth Quarter and Full Year 2016 Financial Results 26
6.6 Feb 27, 2017: Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 27
6.7 Feb 22, 2017: Fresenius Medical Care delivers strong 2016 results and sets ambitious growth targets for 2017 27
6.8 Jan 09, 2017: Vital Therapies Provides Corporate Update 31
6.9 Dec 02, 2016: Change in Investor Relations Management - Dr. Dominik Heger joins Fresenius Medical Care 32
6.10 Dec 01, 2016: Fresenius Medical Care will focus on IFRS reporting and discontinue U.S. GAAP financial statements 32
6.11 Nov 04, 2016: Alliqua BioMedical Reports Third Quarter and Nine-Months Fiscal Year 2016 Financial Results 33
6.12 Nov 03, 2016: Vital Therapies Announces Third Quarter Financial Results 35
6.13 Oct 27, 2016: Fresenius Medical Care reports strong third quarter and confirms full year guidance 36
6.14 Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue 39
6.15 Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for November 4th 40
6.16 Sep 13, 2016: Vital Therapies Provides Corporate Update 40
6.17 Aug 15, 2016: Vital Therapies Announces Appointment of Former Receptos President and CEO Faheem Hasnain to Its Board of Directors 41
6.18 Aug 09, 2016: Alliqua BioMedical Reports Second Quarter and Six Months Fiscal Year 2016 Financial Results 42
6.19 Aug 02, 2016: Vital Therapies Announces Second Quarter Financial Results 44
6.20 Jul 11, 2016: Ian Crosbie Joins Sequana Medical as Chief Financial Officer 45
6.21 Jul 07, 2016: Alliqua BioMedical Announces Preliminary Second Quarter of Fiscal Year 2016 Revenue 45
6.22 Jul 01, 2016: Former Bayer and Pharmacia Senior Executive Rolf A. Classon Joins the Sequana Medical AG Board as Chairman 46
6.23 May 12, 2016: Fresenius Medical Care expects continued, strong growth - Annual General Meeting approves 19th consecutive dividend increase 46
6.24 May 10, 2016: Alliqua BioMedical Reports First Quarter Financial Results 47
6.25 May 09, 2016: Vital Therapies Announces First Quarter Financial Results 49
6.26 May 03, 2016: Fresenius Medical Care reports strong start to the year 2016 49
7 Appendix 52
7.1 Methodology 52
7.2 About GlobalData 55
7.3 Contact Us 55
7.4 Disclaimer 55
1.1 List of Tables
Table 1: Liver Dialysis Equipment - Pipeline Products by Stage of Development 6
Table 2: Liver Dialysis Equipment - Pipeline Products by Territory 7
Table 3: Liver Dialysis Equipment - Pipeline Products by Regulatory Path 8
Table 4: Liver Dialysis Equipment - Pipeline Products by Estimated Approval Date 9
Table 5: Liver Dialysis Equipment - Ongoing Clinical Trials 10
Table 6: Liver Dialysis Equipment Companies - Pipeline Products by Stage of Development 11
Table 7: Liver Dialysis Equipment - Pipeline Products by Stage of Development 11
Table 8: Alliqua BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview 12
Table 9: SEPET Liver Assist Device - Product Status 12
Table 10: SEPET Liver Assist Device - Product Description 13
Table 11: Excorp Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 13
Table 12: Bioartificial Liver System - Product Status 14
Table 13: Bioartificial Liver System - Product Description 14
Table 14: Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Pipeline Products & Ongoing Clinical Trials Overview 15
Table 15: Care Flow Engine - Product Status 15
Table 16: Care Flow Engine - Product Description 15
Table 17: Hep-Art Medical Devices BV Pipeline Products & Ongoing Clinical Trials Overview 16
Table 18: HepaRG-BAL - Product Status 16
Table 19: HepaRG-BAL - Product Description 16
Table 20: University College London Pipeline Products & Ongoing Clinical Trials Overview 17
Table 21: Bioartificial Liver - Product Status 17
Table 22: Bioartificial Liver - Product Description 17
Table 23: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 18
Table 24: Bioartificial Liver - Product Status 18
Table 25: Bioartificial Liver - Product Description 18
Table 26: Vital Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 27: ELAD - Product Status 19
Table 28: ELAD - Product Description 19
Table 29: Yaqrit Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
Table 30: DIALIVE Liver Dialysis Device - Product Status 20
Table 31: DIALIVE Liver Dialysis Device - Product Description 20
Table 32: Yaqrit Ltd - Ongoing Clinical Trials Overview 21
Table 33: DIALIVE Liver Dialysis Device - A Multi-centre, Randomised Controlled Study, to Evaluate the Safety and Performance of The DIALIVE Liver Dialysis Device (LDD) in Patients With Acute on Chronic Liver Failure (ACLF) Versus Standard of Care (SOC) 21
Table 34: Glossary 54
1.2 List of Figures
Figure 1: Liver Dialysis Equipment - Pipeline Products by Stage of Development 6
Figure 2: Liver Dialysis Equipment - Pipeline Products by Territory 7
Figure 3: Liver Dialysis Equipment - Pipeline Products by Regulatory Path 8
Figure 4: Liver Dialysis Equipment - Pipeline Products by Estimated Approval Date 9
Figure 5: Liver Dialysis Equipment - Ongoing Clinical Trials 10
